Volume 16 (2018): Issue 10 (Oct 2018)

in Journal of the National Comprehensive Cancer Network
Online ISSN:
1540-1413
Print ISSN:
1540-1405
Cover Journal of the National Comprehensive Cancer Network
NCCN News
Pages: xxii–xxx
Oncology Research Program
Pages: xxxiii–xxxiv
One Size Fits All? Really?
By: Margaret Tempero
Pages: 1161
Shades of Survivorship
By: Elyse R. Park, Jeffrey Peppercorn, and Areej El-Jawahri
Pages: 1163–1165
First-Line Treatment of Widely Metastatic BRAF-Mutated Salivary Duct Carcinoma With Combined BRAF and MEK Inhibition
By: Victor T.G. Lin, Lisle M. Nabell, Sharon A. Spencer, William R. Carroll, Shuko Harada, and Eddy S. Yang
Pages: 1166–1170
NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018
By: Gregory P. Kalemkerian, Billy W. Loo Jr, Wallace Akerley, Albert Attia, Michael Bassetti, Yanis Boumber, Roy Decker, M. Chris Dobelbower, Afshin Dowlati, Robert J. Downey, Charles Florsheim, Apar Kishor P. Ganti, John C. Grecula, Matthew A. Gubens, Christine L. Hann, James A. Hayman, Rebecca Suk Heist, Marianna Koczywas, Robert E. Merritt, Nisha Mohindra, Julian Molina, Cesar A. Moran, Daniel Morgensztern, Saraswati Pokharel, David C. Portnoy, Deborah Rhodes, Chad Rusthoven, Jacob Sands, Rafael Santana-Davila, Charles C. Williams Jr, Karin G. Hoffmann, and Miranda Hughes
Pages: 1171–1182
A Routine Laboratory Data–Based Model for Predicting Recurrence After Curative Resection of Stage II Colorectal Cancer
By: Zhong Ye, Chun Wang, Limin Guo, Juan P. Palazzo, Zhixing Han, Yinzhi Lai, Jing Jiang, James A. Posey, Atrayee Basu Mallick, Bingshan Li, Li Jiang, and Hushan Yang
Pages: 1183–1192
Systemic Therapy for Combined Hepatocellular-Cholangiocarcinoma: A Single-Institution Experience
By: Nikolaos A. Trikalinos, Amy Zhou, Maria B. Majella Doyle, Kathryn J. Fowler, Ashley Morton, Neeta Vachharajani, Manik Amin, Jesse W. Keller, William C. Chapman, Elizabeth M. Brunt, and Benjamin R. Tan
Pages: 1193–1199
A Study of Novel Febrile Neutropenia Risk Factors Related to Bone Marrow or Immune Suppression, Barrier Function, and Bacterial Flora
By: Leila Family, Yanli Li, Lie Hong Chen, John H. Page, Zandra K. Klippel, and Chun Chao
Pages: 1201–1208
Tumor Board Conferences for Multidisciplinary Skin Cancer Management: A Survey of US Cancer Centers
By: Shoko Mori, Cristian Navarrete-Dechent, Tatyana A. Petukhova, Erica H. Lee, Anthony M. Rossi, Michael A. Postow, Lara A. Dunn, Benjamin R. Roman, Vivian T. Yin, Daniel G. Coit, Travis J. Hollmann, Klaus J. Busam, Kishwer S. Nehal, and Christopher A. Barker
Pages: 1209–1215
Survivorship, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
By: Crystal S. Denlinger, Tara Sanft, K. Scott Baker, Gregory Broderick, Wendy Demark-Wahnefried, Debra L. Friedman, Mindy Goldman, Melissa Hudson, Nazanin Khakpour, Allison King, Divya Koura, Robin M. Lally, Terry S. Langbaum, Allison L. McDonough, Michelle Melisko, Jose G. Montoya, Kathi Mooney, Javid J. Moslehi, Tracey O'Connor, Linda Overholser, Electra D. Paskett, Jeffrey Peppercorn, William Pirl, M. Alma Rodriguez, Kathryn J. Ruddy, Paula Silverman, Sophia Smith, Karen L. Syrjala, Amye Tevaarwerk, Susan G. Urba, Mark T. Wakabayashi, Phyllis Zee, Nicole R. McMillian, and Deborah A. Freedman-Cass
Pages: 1216–1247
Preventive Health in Cancer Survivors: What Should We Be Recommending?
By: Linda S. Overholser and Carlin Callaway
Pages: 1251–1258
Immune Checkpoint Inhibitor Therapy in Breast Cancer
By: Cesar A. Santa-Maria and Rita Nanda
Pages: 1259–1268
Toward a Personalized Approach in the Treatment of Salivary Ductal Carcinoma
By: Frederick D. Tsai and Robert I. Haddad
Pages: 1269–1270
  • Collapse
  • Expand